Alimera Sciences to Hold Conference Call to Discuss Third Quarter 2010 Financial Results
ATLANTA, Oct 25, 2010 (GlobeNewswire via COMTEX) -- Alimera Sciences, Inc. /quotes/comstock/15*!alim/quotes/nls/alim (ALIM 10.87, +0.15, +1.40%) ("Alimera"), a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that it will release its third quarter 2010 financial results after the market close on Thursday, November 4, 2010. An investor conference call will follow on the same day at 4:30 p.m. ET.
The conference call will be hosted by Dan Myers, President and Chief Executive Officer, and Rick Eiswirth, Chief Operating Officer and Chief Financial Officer.
To participate in the call, please dial (877) 369-6586 (U.S. and Canada) or (253) 237-1165 (international). A live webcast will be available on the Investor Relations section of the corporate website at alimerasciences.com.
A replay of the conference call will be available beginning November 4, 2010 at 7:30 p.m. ET and ending on November 18, 2010 by dialing (800) 642-1687 (U.S. and Canada) or (706) 645-9291 (international), Conference ID Number: 20089467. A replay of the webcast will be available on the corporate website for two weeks, through November 18, 2010.
About Alimera Sciences, Inc.
marketwatch.com |
